Richard E Royal
 Professor
                            Surgical Oncology                                                        
MD Anderson Cancer Center
                                                        United States of America
                        
Biography
Degree-Granting Education: 1988 :Oregon Health Sciences University, School of Medicine, Portland, OR, USA, MD, Medicine 1984 :Eastern Mennonite University, Harrisonburg, VA, USA, BS, Biology Postgraduate Training 2001-2002 :Medical Ethics Internship, The University of Texas MD Anderson Cancer Center, Houston, TX 2001-2003 :Surgical Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX 1997-2000 :General Surgery Residency, University of Maryland, Baltimore, MD 1994-1997 :Surgical Oncology Fellowship, National Institutes of Health - National Cancer Institute, Bethesda, MD 1993-1994 :Immunotherapy Fellowship, National Institutes of Health - National Cancer Institute, Bethesda, MD 1991-1993 :Pediatric Surgery Research Fellowship, University of Cincinnati - Children's Hospital Medical Center, Cincinnati, OH 1988-1991 :General Surgery Residency, Surgery, York Hospital, York, PA During fifteen years of residencies and fellowships, Dr Royal developed expertise in Surgical Oncology, Tumor Immunology and Immunotherapy. His research has focused on tumor immunology of melanoma and pancreatic cancer. Following training, Dr Royal moved directly into a Senior Investigator position at the NIH Intramural program. Thereafter he joined the staff at M. D. Anderson Cancer Center as an Associate Professor of Surgical Oncology. The focus of his research is manipulation of immunity to mediate tumor regression. This has included bench investigation, including an ASCO merit award winning project, and translational clinical trials. Clinical expertise includes mastery of a rare set of therapeutic operations know as regional perfusion procedures including isolated limb perfusion, peritoneal perfusion and isolated hepatic perfusion.
Research Interest
tumor immunology,Surgical Oncology
Publications
- 
                            Overman MJ, Fournier K, Hu CY, Eng C, Taggart M, Royal RE, Mansfield P, Chang GJ. Improving the AJCC/TNM Staging for Adenocarcinomas of the Appendix: The Prognostic Impact of Histological Grade. Ann Surg 257 (6) :1072-8, 2013. 
- 
                            Bilen MA, Taggart MW, Fournier K, Ellis LM, Mansfield PF, Eng C, Royal RE, Overman MJ. Pathologic complete response in poorly differentiated adenocarcinomas of the appendix: a case series. Acta Oncol 52 (5) :1044-6, 2013 
- 
                            Rueth NM, Xing Y, Chiang YJ, Cromwell KD, Ross MI, Lee JE, Gershenwald JE, Royal RE, Cormier JN. Is Surveillance Imaging Effective for Detecting Surgically Treatable Recurrences in Patients With Melanoma? A Comparative Analysis of Stage-Specific Surveillance Strategies. Ann Surg 259 (6) :1215-22, 2014 

